{"id":"https://openalex.org/W2508076331","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.tps2079","title":"A randomized, phase 3, open-label study of nivolumab versus temozolomide (TMZ) in combination with radiotherapy (RT) in adult patients (pts) with newly diagnosed, O-6-methylguanine DNA methyltransferase (MGMT)-unmethylated glioblastoma (GBM): CheckMate-498.","display_name":"A randomized, phase 3, open-label study of nivolumab versus temozolomide (TMZ) in combination with radiotherapy (RT) in adult patients (pts) with newly diagnosed, O-6-methylguanine DNA methyltransferase (MGMT)-unmethylated glioblastoma (GBM): CheckMate-498.","publication_year":2016,"publication_date":"2016-05-20","ids":{"openalex":"https://openalex.org/W2508076331","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.tps2079","mag":"2508076331"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2016.34.15_suppl.tps2079","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.tps2079","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.tps2079","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037596103","display_name":"John Howard Sampson","orcid":"https://orcid.org/0000-0002-0104-7658","observed_orcids":["https://orcid.org/0000-0002-0104-7658"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John H. Sampson","raw_affiliation_strings":["Duke University Medical Center, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University Medical Center, Durham, NC;","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033270808","display_name":"Antonio M. P. Omuro","orcid":"https://orcid.org/0000-0003-4299-3664","observed_orcids":["https://orcid.org/0000-0003-4299-3664","https://orcid.org/0000-0002-7007-2224"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Antonio Marcilio Padula Omuro","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057141936","display_name":"Matthias Preusser","orcid":"https://orcid.org/0000-0003-3541-2315","observed_orcids":["https://orcid.org/0000-0003-3541-2315"]},"institutions":[{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Matthias Preusser","raw_affiliation_strings":["Medical University of Vienna, Vienna, Austria;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of Vienna, Vienna, Austria;","institution_ids":["https://openalex.org/I76134821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011340023","display_name":"Michael K. Lim","orcid":"https://orcid.org/0000-0003-0523-3076","observed_orcids":["https://orcid.org/0000-0003-0523-3076"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210150714","display_name":"Johns Hopkins Hospital","ror":"https://ror.org/05cb1k848","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210150714"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Lim","raw_affiliation_strings":["The Johns Hopkins Hospital, Baltimore, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Johns Hopkins Hospital, Baltimore, MD;","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210150714"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090305344","display_name":"Nicholas Arthur Butowski","orcid":"https://orcid.org/0000-0001-5162-2406","observed_orcids":["https://orcid.org/0000-0001-5162-2406"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas A. Butowski","raw_affiliation_strings":["University of California, San Francisco, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063511816","display_name":"Timothy Francis Cloughesy","orcid":"https://orcid.org/0000-0002-8656-7483","observed_orcids":["https://orcid.org/0000-0002-8656-7483"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy Francis Cloughesy","raw_affiliation_strings":["University of California, Los Angeles, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Los Angeles, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020621550","display_name":"Lewis C. Strauss","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lewis C. Strauss","raw_affiliation_strings":["Bristol-Myers Squibb, Princeton, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Princeton, NJ;","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047397920","display_name":"Robert Raymond Latek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Raymond Latek","raw_affiliation_strings":["Bristol-Myers Squibb, Princeton, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Princeton, NJ;","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041689773","display_name":"Prashni Paliwal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Prashni Paliwal","raw_affiliation_strings":["Bristol-Myers Squibb, Princeton, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Princeton, NJ;","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017177249","display_name":"Michael Weller","orcid":"https://orcid.org/0000-0002-1748-174X","observed_orcids":["https://orcid.org/0000-0002-1748-174X"]},"institutions":[{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Michael Weller","raw_affiliation_strings":["University Hospital Zurich, Zurich, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Zurich, Zurich, Switzerland;","institution_ids":["https://openalex.org/I4210100468"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059965175","display_name":"David A. Reardon","orcid":"https://orcid.org/0000-0001-6674-0157","observed_orcids":["https://orcid.org/0000-0001-6674-0157"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A. Reardon","raw_affiliation_strings":["Dana-Farber Cancer Institute and Harvard University School of Medicine, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute and Harvard University School of Medicine, Boston, MA;","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":11,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":53,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"34","issue":"15_suppl","first_page":"TPS2079","last_page":"TPS2079"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9120000004768372},{"id":"https://openalex.org/keywords/mgmt-unmethylated","display_name":"MGMT unmethylated","score":0.9070000052452087},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9890000224113464},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":1.0},{"id":"https://openalex.org/keywords/radiotherapy","display_name":"radiotherapy","score":0.9210000038146973},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8429999947547913},{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.7070000171661377},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7250000238418579},{"id":"https://openalex.org/keywords/newly-diagnosed-glioblastoma","display_name":"newly diagnosed glioblastoma","score":0.9010000228881836},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5440000295639038},{"id":"https://openalex.org/keywords/immunotherapy-versus-chemotherapy","display_name":"immunotherapy versus chemotherapy","score":0.5849999785423279},{"id":"https://openalex.org/keywords/mgmt-promoter-methylation","display_name":"MGMT promoter methylation","score":0.8040000200271606},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.796999990940094},{"id":"https://openalex.org/keywords/neuropsychological-outcomes","display_name":"neuropsychological outcomes","score":0.8849999904632568}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8882224559783936},{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.869583010673523},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.8579410314559937},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6460800170898438},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6452443599700928},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.5410410761833191},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5390036106109619},{"id":"https://openalex.org/C2780964509","wikidata":"https://www.wikidata.org/wiki/Q416975","display_name":"Dacarbazine","level":3,"score":0.5229730606079102},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.41904258728027344},{"id":"https://openalex.org/C2778997737","wikidata":"https://www.wikidata.org/wiki/Q1693598","display_name":"Nasopharyngeal carcinoma","level":3,"score":0.4169181287288666},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.37870028614997864},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.36261075735092163},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.35125499963760376},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.24233517050743103},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.23306992650032043},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.21267390251159668},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2016.34.15_suppl.tps2079","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.tps2079","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.tps2079","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8299999833106995}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2119925221","https://openalex.org/W2070226426","https://openalex.org/W4237783004","https://openalex.org/W350597403","https://openalex.org/W2130852442","https://openalex.org/W2157027442","https://openalex.org/W2314557535","https://openalex.org/W2081797247","https://openalex.org/W2078219238","https://openalex.org/W2121585125"],"abstract_inverted_index":{"TPS2079":[0],"Background:":[1],"GBM,":[2,60],"the":[3,78,164],"most":[4],"common":[5],"primary":[6,165,234],"brain":[7],"tumor":[8,274],"in":[9,23,67,89,119,123,179],"adults,":[10],"has":[11,82],"an":[12,36,283],"aggressive":[13],"clinical":[14,24,84],"course":[15],"and":[16,86,97,197,253,263,272,276],"a":[17,71,104,131,296],"median":[18],"survival":[19,88,112,252,255],"of":[20,29,114,299],"15\u201318":[21],"months":[22],"trial":[25,135,303],"populations.":[26],"Approximately":[27,204],"40%":[28],"pts":[30,50,90,124,139,180,206],"with":[31,35,42,51,58,91,121,125,140,161,185,192,240,282],"GBM":[32,52,178,196,201],"have":[33],"tumors":[34,142],"MGMT-methylated":[37,141],"promoter,":[38],"which":[39],"is":[40,64,103,236],"associated":[41],"sensitivity":[43],"to":[44,77,109,149,210,237,294],"TMZ.":[45,224],"New":[46],"treatment":[47,194],"options":[48],"for":[49,56,195,270],"are":[53,202],"desirable,":[54],"particularly":[55],"those":[57],"MGMT-unmethylated":[59,128,175],"as":[61,163],"TMZ":[62,152,158,219,245],"efficacy":[63],"historically":[65],"marginal":[66],"this":[68],"population.":[69],"Nivolumab,":[70],"fully":[72],"human":[73],"IgG4":[74],"monoclonal":[75],"antibody":[76],"programmed":[79],"death-1":[80],"receptor,":[81],"shown":[83],"activity":[85],"increased":[87],"metastatic":[92],"melanoma,":[93],"non\u2013small-cell":[94],"lung":[95],"cancer,":[96],"renal":[98],"cell":[99],"carcinoma.":[100],"CheckMate-498":[101],"(NCT02617589)":[102],"phase":[105,133],"3":[106],"study":[107],"designed":[108],"compare":[110,238],"overall":[111],"(OS)":[113],"nivolumab":[115,154,212,241],"or":[116,199,218,230],"TMZ,":[117],"each":[118],"combination":[120],"RT,":[122],"newly":[126,171],"diagnosed":[127],"GBM.":[129],"In":[130],"companion":[132],"2":[134],"(CheckMate-548;":[136],"NCT02667587),":[137],"eligible":[138],"(N":[143],"=":[144],"320)":[145],"will":[146,207,226,267,290],"be":[147,208,268],"randomized":[148,209],"RT":[150,156,214,221,243],"+":[151,153,157,159,213,220,242,246],"vs":[155,244],"placebo,":[160],"OS":[162,239],"objective.":[166],"Methods:":[167],"Eligibility":[168],"criteria":[169],"include":[170,250,259],"diagnosed,":[172],"histologically":[173],"confirmed,":[174],"(centrally":[176],"confirmed)":[177],"aged":[181],"\u2265":[182,189,287],"18":[183],"years":[184],"Karnofsky":[186],"performance":[187],"status":[188],"70.":[190],"Pts":[191],"prior":[193],"recurrent":[198],"secondary":[200,248],"ineligible.":[203],"550":[205],"receive":[211],"followed":[215,222,269],"by":[216,223],"nivolumab,":[217],"Treatment":[225],"continue":[227],"until":[228],"progression":[229],"unacceptable":[231],"toxicity.":[232],"The":[233],"objective":[235],"RT;":[247],"objectives":[249,258],"progression-free":[251],"2-year":[254],"rate.":[256],"Exploratory":[257],"safety,":[260],"biomarker":[261],"analyses,":[262],"neurocognitive":[264],"outcomes.":[265],"Patients":[266],"safety":[271],"tolerability,":[273],"progression,":[275],"survival.":[277],"At":[278],"least":[279],"397":[280],"events,":[281,289],"interim":[284],"analysis":[285],"after":[286],"298":[288],"provide":[291],"90%":[292],"power":[293],"detect":[295],"hazard":[297],"ratio":[298],"<":[300],"0.72.":[301],"Clinical":[302],"information:":[304],"NCT02617589.":[305]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":18},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-06T10:28:23.643775","created_date":"2025-10-10T00:00:00"}